ASH2024注目テーマ③「Late-Breaking Abstracts Session #6」
深い寛解を得たMCLに対する自家移植は
維持療法単独に比べてOSもPFSも改善せず
Lack of Benefit of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts) in First Complete Remission (CR) with Undetectable Minimal Residual Disease (uMRD): Initial Report from the ECOG-ACRIN EA4151 Phase 3 Randomized Trial (#LBA-6)
Timothy S. Fenske(Medical College of Wisconsin, Milwaukee, USA)
2025.01.23